Our multivariate analysis showed that TRAF6 was not an independent prognostic factor for DFS and OS of glioma patients, but univariate analysis demonstrated that TRAF6 could act as an auxiliary prognostic biomarker of patients’ survival. The gene discussed is TRAF6; the disease is central nervous system cancer.